1. Nobilon initiates proof of concept trial for SCH900795, a new intranasal influenza vaccine for annual seasonal use. Available form: Pharmaceutical-Business-Review.com; 2009.
2. Global pandemic influenza action plan to increase vaccine supply,2006
3. Hickling J, D’Hondt E. Review of production technologies for influenza virus vaccines and their suitability in developing countries for influenza pandemic preparedness. Available from: http://www.who.int/entity/vaccine_research/diseases/influenza/Flu_vacc_manuf_tech_report.pdf [accessed 25.11.10].
4. World Health Organization. Options for Live Attenuated Influenza Vaccines (LAIV) in the control of epidemic and pandemic influenza. Geneva. Available from: http://www.who.int/vaccine_research/diseases/influenza/meeting_120707/en/index.html; 2007 [accessed 09.11.10].
5. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines;Davenport;J Infect Dis,1977